LDL apheresis and inflammation - implications for atherosclerosis
Scandinavian Journal of Immunology, 06/12/2012
Hovland A et al. – Even if there are differences between pro and anti–inflammatory biomarkers during Low–density lipoprotein (LDL) apheresis, the consequences for the patients are largely unknown and larger studies need to be performed. Preferably they should be comparing the effect of different LDL apheresis columns on the total inflammatory profile, and this should be related to clinical endpoints.